117 related articles for article (PubMed ID: 25169794)
1. Molecular characterization of immortalized normal and dysplastic oral cell lines.
Dickman CT; Towle R; Saini R; Garnis C
J Oral Pathol Med; 2015 May; 44(5):329-36. PubMed ID: 25169794
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast gene expression profile reflects the stage of tumour progression in oral squamous cell carcinoma.
Lim KP; Cirillo N; Hassona Y; Wei W; Thurlow JK; Cheong SC; Pitiyage G; Parkinson EK; Prime SS
J Pathol; 2011 Mar; 223(4):459-69. PubMed ID: 21294120
[TBL] [Abstract][Full Text] [Related]
3. Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.
Manikandan M; Deva Magendhra Rao AK; Rajkumar KS; Rajaraman R; Munirajan AK
J Oral Pathol Med; 2015 Nov; 44(10):792-800. PubMed ID: 25482863
[TBL] [Abstract][Full Text] [Related]
4. Genetic alterations in oral squamous cell carcinoma progression detected by combining array-based comparative genomic hybridization and multiplex ligation-dependent probe amplification.
Cha JD; Kim HJ; Cha IH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 May; 111(5):594-607. PubMed ID: 21334929
[TBL] [Abstract][Full Text] [Related]
5. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.
Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP
Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196
[TBL] [Abstract][Full Text] [Related]
6. Integrated Analysis and MicroRNA Expression Profiling Identified Seven miRNAs Associated With Progression of Oral Squamous Cell Carcinoma.
Yan ZY; Luo ZQ; Zhang LJ; Li J; Liu JQ
J Cell Physiol; 2017 Aug; 232(8):2178-2185. PubMed ID: 27935034
[TBL] [Abstract][Full Text] [Related]
7. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.
Kozaki K; Imoto I; Mogi S; Omura K; Inazawa J
Cancer Res; 2008 Apr; 68(7):2094-105. PubMed ID: 18381414
[TBL] [Abstract][Full Text] [Related]
8. Genetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies.
Fadlullah MZ; Chiang IK; Dionne KR; Yee PS; Gan CP; Sam KK; Tiong KH; Ng AK; Martin D; Lim KP; Kallarakkal TG; Mustafa WM; Lau SH; Abraham MT; Zain RB; Rahman ZA; Molinolo A; Patel V; Gutkind JS; Tan AC; Cheong SC
Oncotarget; 2016 May; 7(19):27802-18. PubMed ID: 27050151
[TBL] [Abstract][Full Text] [Related]
9. Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cells.
Summerer I; Hess J; Pitea A; Unger K; Hieber L; Selmansberger M; Lauber K; Zitzelsberger H
BMC Genomics; 2015 Sep; 16(1):654. PubMed ID: 26328888
[TBL] [Abstract][Full Text] [Related]
10. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression and localization of decorin in human oral dysplasia and squamous cell carcinoma.
Banerjee AG; Bhattacharyya I; Lydiatt WM; Vishwanatha JK
Cancer Res; 2003 Nov; 63(22):7769-76. PubMed ID: 14633702
[TBL] [Abstract][Full Text] [Related]
12. Genomic DNA Copy Number Aberrations, Histological Diagnosis, Oral Subsite and Aneuploidy in OPMDs/OSCCs.
Castagnola P; Zoppoli G; Gandolfo S; Monticone M; Malacarne D; Cirmena G; Brown D; Aiello C; Maffei M; Marino R; Giaretti W; Pentenero M
PLoS One; 2015; 10(11):e0142294. PubMed ID: 26540282
[TBL] [Abstract][Full Text] [Related]
13. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
15. Expression of p63 protein and mRNA in oral epithelial dysplasia.
Chen YK; Hsue SS; Lin LM
J Oral Pathol Med; 2005 Apr; 34(4):232-9. PubMed ID: 15752259
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
Cai Z; Hao XY; Liu FX
Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
[TBL] [Abstract][Full Text] [Related]
17. Predominant Rab-GTPase amplicons contributing to oral squamous cell carcinoma progression to metastasis.
da Silva SD; Marchi FA; Xu B; Bijian K; Alobaid F; Mlynarek A; Rogatto SR; Hier M; Kowalski LP; Alaoui-Jamali MA
Oncotarget; 2015 Sep; 6(26):21950-63. PubMed ID: 26110570
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer.
Pereira CM; de Carvalho AC; da Silva FR; Melendez ME; Lessa RC; Andrade VCC; Kowalski LP; Vettore AL; Carvalho AL
BMC Cancer; 2018 Feb; 18(1):193. PubMed ID: 29454310
[TBL] [Abstract][Full Text] [Related]
19. Integrative molecular characterization of head and neck cancer cell model genomes.
Tsui IF; Garnis C
Head Neck; 2010 Sep; 32(9):1143-60. PubMed ID: 20014447
[TBL] [Abstract][Full Text] [Related]
20. Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamous-cell carcinoma.
Nakamura E; Kozaki K; Tsuda H; Suzuki E; Pimkhaokham A; Yamamoto G; Irie T; Tachikawa T; Amagasa T; Inazawa J; Imoto I
Cancer Sci; 2008 Jul; 99(7):1390-400. PubMed ID: 18452558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
